DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLATROPINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
METHYLATROPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
80719I460H
Molecule Type:
Small molecule
Molecular Formula:
C18H26NO3+
Molecular Weight:
304.41
AlogP:
2.08
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ADAPALENE; BENZOYL PEROXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
ADAPALENE; BENZOYL PEROXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MPA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBOXETINE
4
Small molecule
Approved
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Diabetic Neuropathies; Pain; Anxiety; Dementia; Fibromyalgia; Schizophrenia; Depressive Disorder
Norepinephrine transporter inhibitor
REBOXETINE
×
Maximum Phase:
4
First Approval:
None
UNII:
947S0YZ36I
Molecule Type:
Small molecule
Molecular Formula:
C19H23NO3
Molecular Weight:
313.4
AlogP:
3.19
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
6.0
Source:
NALBUPHINE SEBACATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NALBUPHINE SEBACATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PERAZINE
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Psychotic Disorders; Schizophrenia
Unknown
PERAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8915147A2B
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3S
Molecular Weight:
339.51
AlogP:
3.93
PSA:
9.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TINEFCON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TINEFCON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLATUZUMAB VEDOTIN-PIIQ
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
POLATUZUMAB VEDOTIN-PIIQ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; VALSARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; VALSARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXYPHENISATIN ACETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
OXYPHENISATIN ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
U0Y1YAL65X
Molecule Type:
Small molecule
Molecular Formula:
C24H19NO5
Molecular Weight:
401.42
AlogP:
3.82
PSA:
81.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
HUMAN C1-ESTERASE INHIBITOR
4
Enzyme
Approved
Unknown
Unknown
Neuromyelitis Optica; Renal Insufficiency; Renal Insufficiency, Chronic; Angioedema; Angioedemas, Hereditary
Coagulation factor XII inhibitor
HUMAN C1-ESTERASE INHIBITOR
×
Maximum Phase:
4
First Approval:
None
UNII:
6KIC4BB60G
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYNOXYLIN
4
Small molecule
Approved
Unknown
Unknown
Infections
Unknown
POLYNOXYLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
E18NBG5EEY
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HMB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HMB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CILNIDIPINE
4
Small molecule
Approved
Unknown
Unknown
Polycystic Kidney, Autosomal Dominant; Cardiovascular Diseases; Hypertension
Voltage-gated L-type calcium channel blocker
CILNIDIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
S85436ZG85
Molecule Type:
Small molecule
Molecular Formula:
C27H28N2O7
Molecular Weight:
492.53
AlogP:
4.28
PSA:
117.0
HBD:
1.0
HBA:
#RotB:
10.0
Source:
IODINE
4
Small molecule
Approved
Unknown
Unknown
Colorectal Neoplasms; Multiple Myeloma; Severe Acute Respiratory Syndrome; Thymoma; Breast Neoplasms; Heart Failure; Respiratory Tract Diseases; Liver Neoplasms; Thyroid Neoplasms
Unknown
IODINE
×
Maximum Phase:
4
First Approval:
None
UNII:
9679TC07X4
Molecule Type:
Small molecule
Molecular Formula:
I2
Molecular Weight:
253.81
AlogP:
1.77
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ARSENIC
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ARSENIC
×
Maximum Phase:
4
First Approval:
None
UNII:
V1I29R0RJQ
Molecule Type:
Small molecule
Molecular Formula:
H3As
Molecular Weight:
77.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
XENAZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
XENAZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
KDU8VH09O8
Molecule Type:
Small molecule
Molecular Formula:
C23H21NO4
Molecular Weight:
375.42
AlogP:
4.71
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
8.0
Source:
CEFAMANDOLE
4
Small molecule
Approved
Unknown
Unknown
Osteomyelitis; Bacterial Infections
Bacterial penicillin-binding protein inhibitor
CEFAMANDOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
5CKP8C2LLI
Molecule Type:
Small molecule
Molecular Formula:
C18H18N6O5S2
Molecular Weight:
462.51
AlogP:
-0.23
PSA:
150.54
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM CHROMATE CR-51
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
SODIUM CHROMATE CR-51
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DITHIAZANINE IODIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DITHIAZANINE IODIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8OEC3RA07X
Molecule Type:
Small molecule
Molecular Formula:
C23H23IN2S2
Molecular Weight:
518.49
AlogP:
6.25
PSA:
7.12
HBD:
0.0
HBA:
#RotB:
5.0
Source:
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAMOSETRON
4
Small molecule
Approved
Unknown
Unknown
Nausea; Neoplasms; Postoperative Nausea and Vomiting; Stomach Neoplasms; Vomiting
Unknown
RAMOSETRON
×
Maximum Phase:
4
First Approval:
None
UNII:
7ZRO0SC54Y
Molecule Type:
Small molecule
Molecular Formula:
C17H17N3O
Molecular Weight:
279.34
AlogP:
2.89
PSA:
50.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHAPYRILENE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Histamine H1 receptor antagonist
METHAPYRILENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
00S42N58OM
Molecule Type:
Small molecule
Molecular Formula:
C14H20ClN3S
Molecular Weight:
297.86
AlogP:
2.71
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
6.0
Source:
LANATOSIDE C
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Sodium/potassium-transporting ATPase inhibitor
LANATOSIDE C
×
Maximum Phase:
4
First Approval:
None
UNII:
5RR3JFZ771
Molecule Type:
Small molecule
Molecular Formula:
C49H76O20
Molecular Weight:
985.13
AlogP:
0.61
PSA:
288.28
HBD:
8.0
HBA:
#RotB:
11.0
Source:
CHLOROQUINE SULPHATE
4
Small molecule
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
CHLOROQUINE SULPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
OE48649K6N
Molecule Type:
Small molecule
Molecular Formula:
C18H28ClN3O4S
Molecular Weight:
417.96
AlogP:
4.81
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVACIZUMAB-AWWB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BEVACIZUMAB-AWWB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
274
275
276
277
278
279
280
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA